Merck | MRK - Vermögenswerte





Vermögenswerte Veränderung Datum
AbbVie USD 147.68B 12.57B 2026-09
Abbott USD 110.43B 23.72B 2026-03
ALKERMES USD 4.44B 42.4M 2026-09
Amgen USD 95.64B 3.14B 2026-06
AstraZeneca USD 119.92B 4.09B 2026-09
Biogen USD 32.05B 32.5M 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Coherus Biosciences USD 191.18M 74.84M 2026-06
Drreddys Laboratories INR 574.48B 4.86B 2026-09
Eli Lilly USD 148.07B 5.79B 2026-09
Gilead Sciences USD 51.41B 2.05B 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
Glaxosmithkline GBP 71.7B 8.83B 2026-09
J&J USD 197.42B 3.64B 2026-09
Medtronic USD 93.31B 278M 2026-06
Merck USD 129.8B 1.12B 2026-06
Novartis USD 117.15B 4.88B 2026-09
Novartis USD 117.15B 1.38B 2026-09
Novo Nordisk DKK 594.94B 35.72B 2026-06
Pacira USD 1.24B 35.44M 2026-06
Perrigo USD 7.61B 373.8M 2026-06
Pfizer USD 204.54B 3.41B 2026-09
Phibro Animal Health USD 1.5B 56.12M 2026-06
Prestige Brands USD 4.57B 1.07B 2026-06
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 130.29B 1.23B 2026-09
Sanofi EUR 129.06B 1.04B 2026-06
United Therapeutics USD 7.22B 505.9M 2026-06
Zoetis USD 15.08B 77M 2026-06